1. Pharma Giant GlaxoSmithKline Signs Mega Deal With Pfizer That Could Change the Face of Global Healthcare

    Pharma Giant GlaxoSmithKline Signs Mega Deal With Pfizer That Could Change the Face of Global Healthcare
    • British pharmaceuticals giant GlaxoSmithKline will combine its consumer health business into a joint venture with US rival Pfizer to create a medical superpower.
    • The deal could forge the largest provider of medicinal products sold directly to the public in the world.
    • The move means that GSK will split into two businesses going forward.

    Two of the world's largest pharmaceuticals companies are set to merge in a joint venture which could have combined sales of nearly $10 billion...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content
  2. Quotes

    1. In the short-term, teaming up with Pfizer means GSK will become over the counter market leader in pretty much all major geographies around the world, and the partnership should bring significant cost savings too.
    2. Ultimately, our goal is to create two exceptional, UK-based global companies, with appropriate capital structures, that are each well positioned to deliver improving returns to shareholders and significant benefits to patients and consumers.
  3. Topics Mentioned

  4. Authors